Wilffert B, Smit G, de Jonge A, Thoolen M J, Timmermans P B, van Zwieten P A
Naunyn Schmiedebergs Arch Pharmacol. 1984 Jun;326(2):91-8. doi: 10.1007/BF00517303.
Additional experimental evidence was obtained for an inhibitory function of prejunctional alpha 2-adrenoceptors and/or dopamine receptors located on noradrenergic neurons innervating the heart and resistance vessels of the pithed normotensive rat. Mixed alpha 2-adrenoceptor/dopamine receptor agonists, differing in selectivity towards either receptor type, i.e. N,N-di-n-propyldopamine (DPDA), 2-N, N-di-n-propylamino-6, 7-dihydroxy-1,2,3,4-tetrahydro-naphthalene (DP-6,7-ADTN), B-HT 920 and B-HT 933 (azepexole) were used. In pithed normotensive rats, DPDA (30 and 100 micrograms/kg/min) dose-dependently inhibited the electrical stimulation-induced increase in diastolic pressure, but did not significantly affect the stimulation-evoked increase in heart rate. The inhibition exerted by DPDA was blocked by haloperidol and sulpiride (0.3 mg/kg of each), but not by yohimbine (1 mg/kg), indicating the involvement of dopamine receptors. In this respect, sulpiride and haloperidol were found approximately equipotent. DP-6,7-ADTN (10 and 30 micrograms/kg/min) impaired both tachycardic and vasoconstrictor responses in a dose-dependent manner. Sulpiride (0.3 mg/kg) only partially restored the DP-6,7-ADTN-depressed stimulation-evoked increase in diastolic pressure, whereas yohimbine (1 mg/kg) alone was without effect. The combination of both antagonists completely prevented the inhibition caused by DP-6,7-ADTN. On the other hand, yohimbine (1 mg/kg), but not sulpiride (0.3 mg/kg), selectively antagonized the DP-6,7-ADTN-induced inhibition of stimulation-evoked tachycardia. B-HT 920 (1, 3 and 10 micrograms/kg/min) very effectively reduced the increase in diastolic pressure and heart rate caused by electrical stimulation.(ABSTRACT TRUNCATED AT 250 WORDS)
在对去大脑正常血压大鼠的心脏和阻力血管进行神经支配的去甲肾上腺素能神经元上,发现了突触前α2-肾上腺素能受体和/或多巴胺受体具有抑制功能的更多实验证据。使用了对两种受体类型选择性不同的混合α2-肾上腺素能受体/多巴胺受体激动剂,即N,N-二正丙基多巴胺(DPDA)、2-N,N-二正丙基氨基-6,7-二羟基-1,2,3,4-四氢萘(DP-6,7-ADTN)、B-HT 920和B-HT 933(阿泽哌唑)。在去大脑正常血压大鼠中,DPDA(30和100微克/千克/分钟)剂量依赖性地抑制电刺激引起的舒张压升高,但对刺激诱发的心率增加没有显著影响。DPDA产生的抑制作用被氟哌啶醇和舒必利(各0.3毫克/千克)阻断,但未被育亨宾(1毫克/千克)阻断,表明多巴胺受体参与其中。在这方面,舒必利和氟哌啶醇的效力大致相当。DP-6,7-ADTN(10和30微克/千克/分钟)以剂量依赖性方式损害心动过速和血管收缩反应。舒必利(0.3毫克/千克)仅部分恢复DP-6,7-ADTN抑制后的刺激诱发的舒张压升高,而单独使用育亨宾(1毫克/千克)则无效。两种拮抗剂联合使用完全阻止了DP-6,7-ADTN引起的抑制作用。另一方面,育亨宾(1毫克/千克)而非舒必利(0.3毫克/千克)选择性地拮抗DP-6,7-ADTN诱导的刺激诱发心动过速的抑制作用。B-HT 920(1、3和10微克/千克/分钟)非常有效地降低了电刺激引起的舒张压和心率升高。(摘要截短于250字)